Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Eris Lifesciences Limited Call Transcript 2020

Feb 10, 2020

61253_rns_2020-02-10_de17aadc-f92b-4092-addd-fd1ceea53f00.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [596 x 137] intentionally omitted <==

Date: 10[th] February, 2020

To
The Department of Corporate Services
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street
Mumbai- 400001
To
National Stock Exchange of India Limited
Exchange Plaza
Bandra Kurla Complex
Bandra (E)
Mumbai-400051
Security Code: 540596 Symbol: ERIS

SUBJECT: INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL PURSUANT TO REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (SEBI LODR, 2015)

Dear Sir/Madam,

This is further to our letter dated 07[th] February, 2020 intimating about the date of the Board of Directors Meeting to inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and nine months ended 31[st] December, 2019.

We wish to inform that pursuant to regulation 30 and other applicable regulations, if any, of the SEBI LODR, 2015 the Company will hold a conference call for analysts and investors on Friday, 14[th] February, 2020. The details of the said call are attached herewith and also available on Company’s website.

Thanking you.

For Eris Lifesciences Limited

==> picture [96 x 66] intentionally omitted <==

_______ Milind Talegaonkar Company Secretary and Compliance Officer Membership No.: A26493

Encl.:a/a

==> picture [596 x 66] intentionally omitted <==

==> picture [101 x 58] intentionally omitted <==

The Senior Management Team of

Eris Lifesciences Limited

Cordially invites you to its

Earnings Conference Call

To discuss the financial and operational performance for

Q3 FY20

Day/Date: Friday, 14[th] February 2020 Time: 4:30 PM, IST

Access Numbers Access Numbers
Primary Number: +91 22 6280 1472
+91 22 7115 8839
Local Dial-in +91-70456 71221
Toll Free Number: USA: 1 866 746 2133
UK: 0 808 101 1573
Singapore: 800 101 2045
HongKong: 800 964 448

We look forward to your participation

RSVP:

Kruti Raval : +91 99090 17419